Expert Interview
A fourth look: Discussing the current treatment landscape for ADHD and the potential of SUNOSI(solriamfetol), a dopamine and norepinephrine reuptake inhibitor
Ticker(s): AXSMInstitution: Self
- Board certified in Psychiatry and Neurology
- Specializes in Child and Adolescent Psychiatry with half of practice having ADHD diagnosis(~100 patients)
- Currently working in Private Practice, counseling and therapy as well as medication management
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
